Refocusing Human Microbiota Research in Infectious and Immune-mediated Diseases: Advancing to the Next Stage

Maria Y Giovanni; Johanna S Schneider; Thomas Calder; Anthony S Fauci

doi:10.1093/infdis/jiaa706

Refocusing Human Microbiota Research in Infectious and Immune-mediated Diseases: Advancing to the Next Stage

J Infect Dis. 2021 Jul 2;224(1):5-8. doi: 10.1093/infdis/jiaa706.

Authors

Maria Y Giovanni¹, Johanna S Schneider¹, Thomas Calder², Anthony S Fauci¹

Affiliations

¹ Office of the Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
² Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Abstract

Changes in the microbiota are associated with disease susceptibility, immune system development, and responses to treatment. Refocusing research to elucidate the causal links between the human microbiota and infectious and immune-mediated diseases will be critical to harnessing its power to prevent, diagnose, and treat such diseases.

Keywords: Immune mediated diseases; Infectious Diseases; microbiome.

Published by Oxford University Press for the Infectious Diseases Society of America 2020.

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Asthma / etiology
Communicable Diseases / etiology*
Communicable Diseases / microbiology
Disease Susceptibility
Fecal Microbiota Transplantation
Humans
Hypersensitivity / etiology
Immune System / physiology
Immune System Diseases / etiology*
Immune System Diseases / microbiology
Microbiota / physiology*